Sanofi SA SAN-FR:Euronext Paris

RT Quote | Exchange | EUR

Last | 5:35 PM CEST

90.80

+0.80 (+0.89%)

Volume

1,205,626

52 week range

80.60 - 104.32

Open90.09
Day High90.87
Day Low89.56
Prev Close90.00
52 Week High104.32
52 Week High Date10/13/23
52 Week Low80.60
52 Week Low Date10/27/23

Key Stats

Market Cap121,022.75M
Shares Out1,251.35M
10 Day Average Volume1.52M
Dividend3.76
Dividend Yield4.14%
Beta0.49
YTD % Change0.97

KEY STATS

Open90.09
Day High90.87
Day Low89.56
Prev Close90.00
52 Week High104.32
52 Week High Date10/13/23
52 Week Low80.60
52 Week Low Date10/27/23
Market Cap121,022.75M
Shares Out1,251.35M
10 Day Average Volume1.52M
Dividend3.76
Dividend Yield4.14%
Beta0.49
YTD % Change0.97

RATIOS/PROFITABILITY

EPS (TTM)3.62
P/E (TTM)25.05
Fwd P/E (NTM)-
EBITDA (TTM)-
ROE (TTM)-
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date05/13/2024
Div Amount3.76
Split Date-
Split Factor-

Latest On Sanofi SA

Novavax stock jumps 50% as Sanofi vaccine deal kicks off a turnaroundMay 13, 2024CNBC.com
Stocks making the biggest moves premarket: Yelp, Sweetgreen, Novavax and moreMay 10, 2024CNBC.com
Novavax partners with Sanofi to commercialize Covid vaccine, develop combo shotsMay 10, 2024CNBC.com
Sanofi CEO Paul Hudson on Q1 results: Hope to gather even more momentum later this yearApril 25, 2024CNBC.com

Content From Our Affiliates

Shah Capital Ends Proxy Fight at Novavax After Sanofi Deal Boost3 Hours AgoTipRanks
Innate Pharma provides clarification regarding SAR443579 designationMay 21, 2024TipRanks
Sanofi says NOTUS data confirm positive Phase 3 BOREAS studyMay 20, 2024TipRanks
Novavax shareholder Shah Capital withdraws campaign against director re-electionMay 20, 2024TipRanks
Strong Buy Rating for Sanofi on Dupixent’s Expansion and Pipeline PotentialMay 16, 2024TipRanks

Profile

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The...

Frederic Oudea

Independent Chairman of the Board

Paul Hudson Ph.D.

Chief Executive Officer, Executive Director, Member of the Executive Committee

Francois-Xavier Roger

Chief Financial Officer, Member of the Executive Committee

Roy Papatheodorou

Executive Vice President, General Counsel, Member of the Executive Committee

Brendan O'Callaghan

Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee

Address

46 Avenue de la Grande Armee

Paris

75017

France

https://www.sanofi.com/